Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Could be 20p by lunchtime.
That is amazing!
I've been here for 12 years now, been through it all I feel. I am really annoyed I deleted my previous LSE account (after some mistaken legal issues from the USA where I cleared my online presence!).
I remember telling everyone at about 400 to be taking profits.
Here is hoping to see that figure again!
Over full ask....being paid atm
With lots more to come over the course of the day.
Nice!
I can see 10 buys at #30,000 or close! That’s certainly at least between a few and a lot.
1 left on 16, now 1 on 19 and 1 on 19.5....the buys are relentless 😎
Transformative news due, they need the Mk Cap up substantially Sar is vulnerable right now. Both TYK2/JAK1 & CHK1 are hot assets maybe finally the ducks are actually lining up….GLA
I can see 5 showing as buys.
And 1 showing as a sell.
What's your definition of 'lots'?
Anyone able to say what L2 is looking like?
A lot of #30,000 (or approx) this morning! Interesting pattern!
I've got my averages down to;
31p (from about £1.40) ISA
21p (from about 70p) SIPP
Could have been worse!
Hi Mitty, those numbers are remarkably similar to mine. I still intend to stay for the long game, I just hold more shares than I thought I would.
Wtg
Thanks.
Well done, I managed to bring my average down to 22.5p from about 75p
To be expected but i suspect much more to come with some good news......I am holding still and have increased that holding 3 fold since the drop. good luck all......x
Buys at 15p moving up :O)
As it’s been said on here many times, it’s a murky and difficult area as a biotech company trying to raise funds. Investment company’s would turn you over in a breath as a few have said recently. Here’s hoping we have come through that difficult period and I’ll check that out lately from Motley. Even though I wouldn’t use them for predictions
Https://www.fool.co.uk/investing-basics/market-sectors/investing-in-biotech-stocks-in-the-uk/
Morning Laura - you are correct in stating the GGP situation is slightly different. However, access to investment funding is the driver as it is considered that there is more Institutional Investor appetite for mining companies in Oz and very little in the UK.
@HBD - I think you are correct and we will never know. I would much prefer the BoD get on with the plan now we are seemingly over our financial glitch. RF have troubles of their own. It may even support the theory that we were deliberately weakened. It is behind us now - onwards and sideways!
What alot of got in common is companies that have needed £5-10mlm per year just to tread water and /or BOD/II holding significant clout and using the "UK market excuse to commit day light robbery l eg Griffiths and 1 other ii holding 60% of REDX and shafting the P.Is
Apparnelty someone called Woodford also tried and failed to do this
As for GGP
At one brief glance that is different as below
During the period, Greatland continued to advance its preparations for a proposed cross-listing on the ASX, with significant progress made. In September 2023, having regard to the listing timetable and activities and opportunities for the business, Greatland decided to defer the ASX cross-listing until 2024. Greatland continues to assess the opportunity to list on the ASX at the appropriate time and is well positioned by the work undertaken to efficiently resume and complete the ASX listing proces
Hi Laz - I can almost imagine a sort of domino effect. RF needed funds to carry out their reverse takeover of SVEN but couldn't raise the cash so their only option was to dump chunks of their portfolio to prop themselves up. That led to the decimation of our sp and a great deal of finger pointing. If the city/AIM weren't in the state they're in then maybe both SAR & RF could've accessed the funding each needed without all the resulting fallout.
I expect we'll never know the real truth of the matter.
The Alpine acquisition bolsters Vertex’s standing in the immunology space as other pharmas look to stand out. Johnson & Johnson CEO Joaquin Duato told investors in February that he sees opportunity for additional M&A in areas like neuroscience and immunology, and Takeda completed its $4 billion purchase of Nimubs’ TYK2 candidate back in February 2023. Other pharmas, like AbbVie, Bristol Myers Squibb and Sanofi, have doubled down on investing in immunology.
https://www.fiercebiotech.com/biotech/vertex-pays-49-billion-hike-alpines-immunology-trail
-----------------------------------